Monte Rosa Therapeutics, Inc.GLUENASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank67
Studio
Year-over-Year Change

Cash generated from core business operations

Latest
$-22.80M
↑ 22% vs avg
Percentile
P67
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
$-29.38M
Historical baseline
PeriodValueYoY Change
TTM$-22.80M-154.3%
2024$42.00M+195.9%
2023$-43.80M+52.6%
2022$-92.47M-55.8%
2021$-59.36M-157.5%
2020$-23.05M-273.4%
2019$-6.17M-